AG Mednet Partners with Leading German CRO for Efficient Clinical Trial Data Management

To make trials more efficient and ensure compliance, syneed medidata GmbH, an independent CRO in Germany, has signed a Master Services Agreement with Boston’s AG Mednet.

Read More...

AG Mednet Helps Sponsors Comply with New FDA Guidance for Clinical Trials

Improved quality-control measures in clinical trials are gaining traction. AG Mednet driven by its mission of quality at the source for image-intensive trials helps sponsors and core labs comply with the FDA’s newly stated guidance.

Read More...

AG Mednet Named “Innovative Technology of the Year” Finalist by the Mass Technology Leadership Council

AG Mednet’s Submission Quality & Compliance software was recently named a finalist for the Massachusetts Technology Leadership Council’s 2013 Innovative Technology of the Year for Healthcare/Life Sciences. The award was announced before a crowd of more than 200 tech executives at the Microsoft NERD Center in Cambridge, Massachusetts.

Read More...

AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance

On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a changing clinical trial research landscape. Among the clinical trial leaders in attendance will be AG Mednet CEO Abraham Gutman who will moderate a special program about successful site leadership and disruptive technologies transforming investigator sites and challenging old assumptions among global networks.

Read More...

AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab

AG Mednet today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance software, MDHVC is strengthening its commitment to quality in multi-center and multi-national cardiovascular trials by immediately detecting image submission errors that slow down the clinical trial process and add unnecessary costs for sponsors.

Read More...

Boston CEO Abraham Gutman Named Clinical Trial Industry Innovator

Founder, President and CEO of AG Mednet, honored as one of 20 innovators changing the face of the clinical trial industry by The CenterWatch Monthly The CenterWatch Monthly – one of the nation’s leading pharmaceutical and clinical trial industry publications – has selected Boston’s Abraham Gutman as one of the 20 innovators changing the face […]

Read More...

AG Mednet and Japan’s Biovisiq Bring Zero-Delay Clinical Trial Solutions to Asian Pharmaceutical Market

Executing its mission to bring zero-delay imaging technology to clinical trials around the world, AG Mednet today announced the signing of a Master Services Agreement with Biovisiq, a Japanese imaging core laboratory (ICL). As the adoption of Asia and Japan-specific clinical trials continues to grow, AG Mednet and Biovisiq are partnering to set the new industry standard for imaging data quality, compliance and efficiency.

Read More...

AG Mednet Announces Cloud Storage Solution with On-Demand Access to Clinical Trial Data

Imaging intensiveclinical trials create a tremendous amount of data – several gigabytes per subject – and require storage for a minimum of seven years for regulatory compliance. To support the need for storage and streamlined access to data during and after a clinical trial, AG Mednet today announced AG Mednet Storage – a Part 11 compliant repository with on-demand access to clinical trial image data.

Read More...

AG Mednet Licenses Software from Columbia University to Reduce Clinical Trial Protocol Amendments and Unnecessary Costs

Unnecessary procedures and amendments to clinical trial protocols cost sponsors more than $5 billion per year and are responsible for 20% of clinical trial budgets, according to recent research. To help reduce these costs and create zero-delay clinical trials, AG Mednet, Inc. has licensed from Columbia University advanced image analysis technology developed by Drs. Lawrence Schwartz, Binsheng Zhao and Yongqiang Tan at Columbia University Medical Center that aims to verify certain clinical study data prior to submission, a process that could reduce unnecessary procedures, protocol amendments and cost overruns for pharmaceutical clinical trials.

Read More...

ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results

AG Mednet, Inc. today announced that it has signed an OEM agreement with ICON Medical Imaging, a division of ICON plc, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into ICON’s imaging trial offerings. AG Mednet provides the quality assurance and compliance technology necessary for clinical trials to operate with zero delay.

Read More...